Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Human Il-23 Is Essential for Ifn-Γ–Dependent Immunity to Mycobacteria Publisher Pubmed



Philippot Q1, 2 ; Ogishi M3 ; Bohlen J1, 2 ; Puchan J4 ; Arias AA3, 5, 6 ; Nguyen T7, 8 ; Martinfernandez M9, 10, 11, 12, 13 ; Conil C1, 2 ; Rinchai D3 ; Momenilandi M1, 2 ; Mahdaviani SA14 ; Keramatipour M15 ; Rosain J1, 2 ; Yang R3 Show All Authors
Authors
  1. Philippot Q1, 2
  2. Ogishi M3
  3. Bohlen J1, 2
  4. Puchan J4
  5. Arias AA3, 5, 6
  6. Nguyen T7, 8
  7. Martinfernandez M9, 10, 11, 12, 13
  8. Conil C1, 2
  9. Rinchai D3
  10. Momenilandi M1, 2
  11. Mahdaviani SA14
  12. Keramatipour M15
  13. Rosain J1, 2
  14. Yang R3
  15. Khan T16
  16. Neehus AL1, 2
  17. Materna M1, 2
  18. Han JE3
  19. Peel J3
  20. Mele F17
  21. Weisshaar M4
  22. Jovic S17
  23. Bastard P1, 2, 3, 18
  24. Levy R1, 2, 18
  25. Le Voyer T1, 2
  26. Zhang P3
  27. Renkilaraj MRLM1, 2
  28. Arangofranco CA1, 5
  29. Pelham S3
  30. Seeleuthner Y1, 2
  31. Pochon M1, 2
  32. Ata MMA16
  33. Al Ali F16
  34. Migaud M1, 2
  35. Soudee C1, 2
  36. Kochetkov T3
  37. Molitor A19, 20
  38. Carapito R19, 20, 21
  39. Bahram S19, 20, 21
  40. Boisson B1, 2, 3
  41. Fieschi C22
  42. Mansouri D14, 23
  43. Marr N16, 24, 25
  44. Okada S26
  45. Shahrooei M27, 28
  46. Parvaneh N29
  47. Chavoshzadeh Z30
  48. Cobat A1, 2, 3
  49. Bogunovic D10, 11, 12, 13, 14
  50. Abel L1, 2, 3
  51. Tangye SG8, 9
  52. Ma CS8, 9
  53. Beziat V1, 2, 3
  54. Sallusto F4, 17
  55. Boissondupuis S1, 2, 3
  56. Bustamante J1, 2, 3, 31
  57. Casanova JL1, 2, 3, 32, 33
  58. Puel A1, 2, 3
Show Affiliations
Authors Affiliations
  1. 1. Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Sante et de la Recherche Medicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France
  2. 2. University Paris Cite, Imagine Institute, Paris, France
  3. 3. St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, United States
  4. 4. Institute of Microbiology, ETH Zurich, Zurich, Switzerland
  5. 5. Primary Immunodeficiencies Group, University of Antioquia (UdeA), Medellin, Colombia
  6. 6. School of Microbiology, University of Antioquia (UdeA), Medellin, Colombia
  7. 7. Garvan Institute of Medical Research, Darlinghurst, NSW, Australia
  8. 8. School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia
  9. 9. Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, United States
  10. 10. Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
  11. 11. Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
  12. 12. Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, United States
  13. 13. Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
  14. 14. Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  15. 15. Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  16. 16. Department of Human Immunology, Sidra Medicine, Doha, Qatar
  17. 17. Institute for Research in Biomedicine, Universita della Svizzera italiana, Bellinzona, Switzerland
  18. 18. Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, AP-HP, Paris, France
  19. 19. Molecular Immuno-Rheumatology Laboratory, INSERM UMR_S1109, GENOMAX Platform, Faculty of Medicine, OMICARE University Hospital Federation, Immunology and Hematology Research Center, Research Center in Biomedicine of Strasbourg (CRBS), Federation of Translational Medicine of Strasbourg (FMTS), University of Strasbourg, Strasbourg, France
  20. 20. Interdisciplinary Thematic Institute (ITI) of Precision Medicine of Strasbourg, Strasbourg, France
  21. 21. Immunology Laboratory, Biology Technical Platform, Biology Pole, New Civil Hospital, Strasbourg, France
  22. 22. Clinical Immunology Department, Saint Louis Hospital, Paris, France
  23. 23. Clinical Tuberculosis and Epidemiology Research Centre, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  24. 24. College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar
  25. 25. Institute of Translational Immunology, Brandenburg Medical School, Brandenburg an der Havel, Germany
  26. 26. Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-Ku, Hiroshima-Shi, Hiroshima, Japan
  27. 27. Clinical and Diagnostic Immunology, Department of Microbiology, Immunology, and Transplantation, KU Leuven, Belgium
  28. 28. Dr. Shahrooei Lab, 22 Bahman St., Ashrafi Esfahni Blvd, Teheran, Iran
  29. 29. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Teheran, Iran
  30. 30. Pediatric Infections Research Center, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  31. 31. Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, AP-HP, Paris, France
  32. 32. Howard Hughes Medical Institute, New York, NY, United States
  33. 33. Department of Pediatrics, Necker Hospital for Sick Children, Paris, France

Source: Science Immunology Published:2023


Abstract

Patients with autosomal recessive (AR) IL-12p40 or IL-12Rβ1 deficiency display Mendelian susceptibility to mycobacterial disease (MSMD) due to impaired IFN-γ production and, less commonly, chronic mucocutaneous candidiasis (CMC) due to impaired IL-17A/F production. We report six patients from four kindreds with AR IL-23R deficiency. These patients are homozygous for one of four different loss-of-function IL23R variants. All six patients have a history of MSMD, but only two suffered from CMC. We show that IL-23 induces IL-17A only in MAIT cells, possibly contributing to the incomplete penetrance of CMC in patients unresponsive to IL-23. By contrast, IL-23 is required for both baseline and Mycobacterium-inducible IFN-γ immunity in both Vδ2+ γδ T and MAIT cells, probably contributing to the higher penetrance of MSMD in these patients. Human IL-23 appears to contribute to IL-17A/F–dependent immunity to Candida in a single lymphocyte subset but is required for IFN-γ–dependent immunity to Mycobacterium in at least two lymphocyte subsets. Copyright © 2023 The Authors, some rights reserved.
Other Related Docs
15. Common Presentations and Diagnostic Approaches, Stiehm's Immune Deficiencies: Inborn Errors of Immunity (2020)
21. Il-35, a Double-Edged Sword in Cancer, Journal of Cellular Biochemistry (2020)
31. Defects in Innate Immunity: Receptors and Signaling Components, Encyclopedia of Infection and Immunity (2022)
35. Dermatologic Presentations of Hyper Ige Syndrome in Pediatric Patients, Allergy, Asthma and Clinical Immunology (2025)
38. The Role of Th1 and Th17 Cells in Glomerulonephritis, Journal of Nephropathology (2015)
42. The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity, Journal of Allergy and Clinical Immunology: In Practice (2023)
48. The Role of T Helper 17 and Regulatory T Cells in Tumor Microenvironment, Immunopharmacology and Immunotoxicology (2019)
49. Role of Rare Immune Cells in Common Variable Immunodeficiency, Pediatric Allergy and Immunology (2022)